Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (21810)	5/10/1999 4:38:00 PM
From: Wade Spencer Graves	Respond to of 23519

I like trading vvus its a good 10% per day trading stock. It doesn't bother me if it keeps doing this all summer. go vvus!!!!

To: VLAD who wrote (21810)	5/10/1999 4:55:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Vlad...can't fault Leland for the work VVUS has done in the Lab they have done a good job there. PR has been restricted due to the lawsuit that has just been resolved in the last week. Look for more news as they secure patent for PE. Astra/Zeneca and Janssen are doing a good job of marketing and sales overseas. Expect Spain and Italy to approve very soon and collect another $4 million in milestone fees. Look for $0.12 cents profit in the second qtr as was delivered in the 1st qtr. Restocking of inventory to be driven by more countries being launched later this summer and into the fall. Let's see if we can get China approved in the 3rd qtr...another $2 mill milestone payment. With Zona's announcement today does the USA and Japan partnership look better to Astra/Zeneca????????? Will we have a partnership agreement signed by the end of the 2nd qtr??????? Alibra Phase III testing expected to be completed in Sept and we may get Gene Therapy started in Phase I trials in the 4th qtr. Like to see some news on Female SD trials start date, same for PE and Incontinence.